Literature DB >> 24113369

Bimanual technique for insertion and positioning of endothelium-Descemet membrane graft in Descemet membrane endothelial keratoplasty.

Jose L Güell1, Merce Morral, Oscar Gris, Daniel Elies, Felicidad Manero.   

Abstract

PURPOSE: To describe a new bimanual technique for insertion and positioning of endothelium-Descemet membrane (EDM) grafts in Descemet membrane endothelial keratoplasty (DMEK).
METHODS: Prospective, noncomparative, consecutive interventional case series, including 15 pseudophakic eyes of 15 patients treated with DMEK at the Instituto de Microcirugia Ocular, Barcelona, Spain. A bimanual infusion technique was used to introduce and position donor's EDM. Partial tamponade was achieved with 20% sulfur hexafluoride (SF6). Intraocular manipulation time of EDM grafts, rebubbling rate, and endothelial cell density were evaluated.
RESULTS: Six months postoperatively, mean uncorrected visual acuity and best spectacle-corrected visual acuity (BSCVA) improved from 20/100 to 20/50 and from 20/80 to 20/25, respectively (P < 0.001). Six eyes (40%) had ≥ 20/20 BSCVA, and 13 (86%) eyes had ≥ 20/30 BSCVA. Mean donor cell density decreased from 2690 ± 302 to 1998 ± 621 cells per square millimeter, representing a mean cell loss of 26% ± 20%. EDM was stripped successfully in all cases. Mean intraocular manipulation time of donor's EDM (interval between main incision closure and final EDM positioning) was 4.10 ± 0.5 minutes. Intracameral air reinjection was needed in 1 case (6.6%) with a partial peripheral graft detachment. No episodes of immunologic graft rejection were documented.
CONCLUSIONS: Insertion and positioning of EDM grafts in DMEK was successfully achieved using this bimanual infusion technique and 20% SF6 partial tamponade, with a low intraocular manipulation time and very low postoperative rebubbling rates, regardless of the preservation method and the donor's age. However, prospective comparative studies are required to demonstrate the long-term safety compared with other approaches.

Entities:  

Mesh:

Year:  2013        PMID: 24113369     DOI: 10.1097/ICO.0b013e3182933aee

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

Review 1.  [Critical endothelial procedures during posterior lamellar graft preparation and transplantation].

Authors:  T A Fuchsluger; F E Kruse; G Geerling
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

2.  Evolving Techniques in Corneal Transplantation.

Authors:  Grace E Boynton; Maria A Woodward
Journal:  Curr Surg Rep       Date:  2015-02-01

3.  [Influence of 20 % sulfur hexafluoride (SF6) on human corneal endothelial cells : An in vitro study].

Authors:  F Schaub; H G Simons; S Roters; L M Heindl; W Kugler; B O Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

4.  DMEK for the treatment of interface fluid syndrome secondary to failed DSAEK graft: A case report and review of the literature.

Authors:  Nuno Moura-Coelho; Elena Arrondo; Mario Renato Papa-Vettorazzi; João Paulo Cunha; José Luis Güell
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-10

Review 5.  Component corneal surgery: An update.

Authors:  Prafulla K Maharana; Pranita Sahay; Deepali Singhal; Itika Garg; Jeewan S Titiyal; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2017-08       Impact factor: 1.848

6.  Use of Pressurized Air Infusion For Pre Descemet's Endothelial Keratoplasty (PDEK) - The Air Pump Assisted PDEK Technique.

Authors:  Soosan Jacob
Journal:  Open Ophthalmol J       Date:  2018-07-23

7.  Visual outcome of penetrating keratoplasty, deep anterior lamellar keratoplasty and Descemet membrane endothelial keratoplasty.

Authors:  Clàudia Garrido; Genís Cardona; Josep L Güell; Jaume Pujol
Journal:  J Optom       Date:  2017-11-13

8.  "Mouse Sign" on Optical Coherence Tomography of Detached Endothelial Graft Indicates Graft Inversion.

Authors:  Dhivya Ashok Kumar; Shana Sood; Amar Agarwal
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.